OppenheimerFunds’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$1.46M Buy
61,803
+7,749
+14% +$181K ﹤0.01% 944
2018
Q4
$1.2M Sell
54,054
-6,292
-10% -$151K ﹤0.01% 981
2018
Q3
$1.57M Buy
60,346
+3,158
+6% +$87.6K ﹤0.01% 961
2018
Q2
$1.54M Buy
57,188
+1,109
+2% +$29.4K ﹤0.01% 965
2018
Q1
$1.45M Sell
56,079
-4,691
-8% -$128K ﹤0.01% 943
2017
Q4
$1.67M Sell
60,770
-22,869
-27% -$606K ﹤0.01% 991
2017
Q3
$1.88M Buy
83,639
+8,403
+11% +$190K ﹤0.01% 955
2017
Q2
$1.99M Sell
75,236
-2,076
-3% -$55.4K ﹤0.01% 929
2017
Q1
$2.12M Buy
77,312
+1,714
+2% +$43.7K ﹤0.01% 933
2016
Q4
$1.86M Buy
75,598
+14,703
+24% +$310K ﹤0.01% 930
2016
Q3
$1.38M Sell
60,895
-11,486
-16% -$251K ﹤0.01% 944
2016
Q2
$1.37M Buy
72,381
+19,424
+37% +$406K ﹤0.01% 929
2016
Q1
$1.39M Sell
52,957
-21
-0% -$486 ﹤0.01% 928
2015
Q4
$1.36M Buy
+52,978
New +$1.43M ﹤0.01% 965

Other funds holding TBI

OppenheimerFunds's TBI Position: Q1 2019 in Review

OppenheimerFunds increased its Trueblue (TBI) stake by 14% in Q1 2019, buying an estimated $181K and bringing the position to 61,803 shares worth $1.46M. The position accounts for ﹤0.01% of the portfolio, ranked #944.

OppenheimerFunds first reported a position in TBI in Q4 2015 and has held it in 14 quarters since. The position peaked at $2.12M in Q1 2017. 191 funds tracked by Wall St. Rank hold TBI as of Q1 2019.

  • OppenheimerFunds held 61,803 shares of Trueblue worth $1.46M as of Q1 2019.
  • OppenheimerFunds bought 7,749 Trueblue shares in Q1 2019, an estimated $181K.
  • Trueblue made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #944 holding.
  • OppenheimerFunds first reported a position in Trueblue in Q4 2015 and has held it in 14 quarters since.
  • OppenheimerFunds's Trueblue position peaked at $2.12M in Q1 2017.
  • 191 funds tracked by Wall St. Rank held Trueblue as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.